As 2020 winds down, we want to look to the year ahead. In this minisode, we sit down with Vynamic’s Life Sciences Sector Advisor, Karen Baldry, to discuss the trends she sees being the most impactful in 2021. The episode opens with a discussion of the COVID-19 vaccine and the shift in focus from clinical trials to supply, distribution, pricing, and access (01:15). Even after a vaccine is available, life sciences organizations will likely still see long term impacts of the pandemic across the business (01:52), with digital becoming an increasing area of concentration and innovation (02:15). The conversation then moves to the impact of these trends (03:00), including changes to future vaccine and drug development, interactions with HCPs (04:05), and investment in omnichannel (5:04). The interview closes with the hope that learnings from 2020 unlock new opportunities for life sciences companies and organizations across the entire healthcare industry (6:09).
No transcript available.
POWERED BY BLUBRRY
